Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibody

Daniel Hofmann, Samantha E. Zak, Elisabeth K. Nyakatura, Eva-Maria Mittler, Russell R. Bakken, Kartik Chandran, John M. Dye, Jonathan R. Lai

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The Sudan virus (SUDV), an ebolavirus, causes severe hemorrhagic fever with human case fatality rates of ∼50%. Previous work from our lab demonstrated the synthetic antibody F4 potently inhibits viral entry and protects against lethal virus challenge in mice [Chen et al., ACS Chem. Biol., 2014, 9, 2263–2273]. Here, we explore mechanistic requirements as well as contribution of the Fc region and function on neutralization and in vivo protection. Live cell imaging demonstrates that the antibody colocalizes with vesicular stomatitis virus particles containing the Sudan virus glycoprotein (VSV-GPSUDV) and that the antibody is rapidly degraded within cellular endosomes. A viral escape mutant contained substitutions on the N-heptad repeat (NHR) segment of GP2, the fusion subunit. Truncation studies indicated that the size of the Fc impacts virus neutralization potential. Finally, we examined the protective efficacy of Fc-null mutants in mice, and found that Fc function was not required for high levels of protection. Altogether, these results indicate that neutralization of SUDV GP-mediated cell entry likely involves blockade of viral membrane fusion within endosomes, and that inhibition of viral entry is the likely mechanism of in vivo protection.

Original languageEnglish (US)
Pages (from-to)289-295
Number of pages7
JournalImmunology Letters
Volume190
DOIs
StatePublished - Oct 1 2017

Fingerprint

Virus Internalization
Sudan
Viruses
Antibodies
Endosomes
Ebolavirus
Vesicular Stomatitis
Virion
Glycoproteins
Fever
Mortality

Keywords

  • Ebola virus
  • Neutralizing antibodies
  • Sudan virus
  • Synthetic antibodies

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibody. / Hofmann, Daniel; Zak, Samantha E.; Nyakatura, Elisabeth K.; Mittler, Eva-Maria; Bakken, Russell R.; Chandran, Kartik; Dye, John M.; Lai, Jonathan R.

In: Immunology Letters, Vol. 190, 01.10.2017, p. 289-295.

Research output: Contribution to journalArticle

@article{02c42d28eb124931b5fe70103e75e069,
title = "Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibody",
abstract = "The Sudan virus (SUDV), an ebolavirus, causes severe hemorrhagic fever with human case fatality rates of ∼50{\%}. Previous work from our lab demonstrated the synthetic antibody F4 potently inhibits viral entry and protects against lethal virus challenge in mice [Chen et al., ACS Chem. Biol., 2014, 9, 2263–2273]. Here, we explore mechanistic requirements as well as contribution of the Fc region and function on neutralization and in vivo protection. Live cell imaging demonstrates that the antibody colocalizes with vesicular stomatitis virus particles containing the Sudan virus glycoprotein (VSV-GPSUDV) and that the antibody is rapidly degraded within cellular endosomes. A viral escape mutant contained substitutions on the N-heptad repeat (NHR) segment of GP2, the fusion subunit. Truncation studies indicated that the size of the Fc impacts virus neutralization potential. Finally, we examined the protective efficacy of Fc-null mutants in mice, and found that Fc function was not required for high levels of protection. Altogether, these results indicate that neutralization of SUDV GP-mediated cell entry likely involves blockade of viral membrane fusion within endosomes, and that inhibition of viral entry is the likely mechanism of in vivo protection.",
keywords = "Ebola virus, Neutralizing antibodies, Sudan virus, Synthetic antibodies",
author = "Daniel Hofmann and Zak, {Samantha E.} and Nyakatura, {Elisabeth K.} and Eva-Maria Mittler and Bakken, {Russell R.} and Kartik Chandran and Dye, {John M.} and Lai, {Jonathan R.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.imlet.2017.09.002",
language = "English (US)",
volume = "190",
pages = "289--295",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",

}

TY - JOUR

T1 - Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibody

AU - Hofmann, Daniel

AU - Zak, Samantha E.

AU - Nyakatura, Elisabeth K.

AU - Mittler, Eva-Maria

AU - Bakken, Russell R.

AU - Chandran, Kartik

AU - Dye, John M.

AU - Lai, Jonathan R.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The Sudan virus (SUDV), an ebolavirus, causes severe hemorrhagic fever with human case fatality rates of ∼50%. Previous work from our lab demonstrated the synthetic antibody F4 potently inhibits viral entry and protects against lethal virus challenge in mice [Chen et al., ACS Chem. Biol., 2014, 9, 2263–2273]. Here, we explore mechanistic requirements as well as contribution of the Fc region and function on neutralization and in vivo protection. Live cell imaging demonstrates that the antibody colocalizes with vesicular stomatitis virus particles containing the Sudan virus glycoprotein (VSV-GPSUDV) and that the antibody is rapidly degraded within cellular endosomes. A viral escape mutant contained substitutions on the N-heptad repeat (NHR) segment of GP2, the fusion subunit. Truncation studies indicated that the size of the Fc impacts virus neutralization potential. Finally, we examined the protective efficacy of Fc-null mutants in mice, and found that Fc function was not required for high levels of protection. Altogether, these results indicate that neutralization of SUDV GP-mediated cell entry likely involves blockade of viral membrane fusion within endosomes, and that inhibition of viral entry is the likely mechanism of in vivo protection.

AB - The Sudan virus (SUDV), an ebolavirus, causes severe hemorrhagic fever with human case fatality rates of ∼50%. Previous work from our lab demonstrated the synthetic antibody F4 potently inhibits viral entry and protects against lethal virus challenge in mice [Chen et al., ACS Chem. Biol., 2014, 9, 2263–2273]. Here, we explore mechanistic requirements as well as contribution of the Fc region and function on neutralization and in vivo protection. Live cell imaging demonstrates that the antibody colocalizes with vesicular stomatitis virus particles containing the Sudan virus glycoprotein (VSV-GPSUDV) and that the antibody is rapidly degraded within cellular endosomes. A viral escape mutant contained substitutions on the N-heptad repeat (NHR) segment of GP2, the fusion subunit. Truncation studies indicated that the size of the Fc impacts virus neutralization potential. Finally, we examined the protective efficacy of Fc-null mutants in mice, and found that Fc function was not required for high levels of protection. Altogether, these results indicate that neutralization of SUDV GP-mediated cell entry likely involves blockade of viral membrane fusion within endosomes, and that inhibition of viral entry is the likely mechanism of in vivo protection.

KW - Ebola virus

KW - Neutralizing antibodies

KW - Sudan virus

KW - Synthetic antibodies

UR - http://www.scopus.com/inward/record.url?scp=85029294668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029294668&partnerID=8YFLogxK

U2 - 10.1016/j.imlet.2017.09.002

DO - 10.1016/j.imlet.2017.09.002

M3 - Article

VL - 190

SP - 289

EP - 295

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

ER -